Quest Laboratories Ltd

Quest Laboratories Other Announcement

Quest Laboratories reported no deviation in IPO fund utilisation for the half year ended September 2026. Its statement was reviewed by the Audit Committee.

Quest Laboratories H1 FY27 Results: Net Profit ₹9 Cr, Up 11.1% YoY

Quest Laboratories approved unaudited standalone half-year results for the period ended September 30, 2026, with a full results statement attached. Revenue, profit and balance sheet figures are disclosed in the enclosed statements.

Key figure

Net profit ₹9 Cr · +11.1% YoY

Quest Laboratories Annual General Meeting

Quest Laboratories Limited held its 28th Annual General Meeting on September 30, 2026. The company discussed and placed standard business resolutions for shareholder consideration and approval.

Quest Laboratories Partnership

Quest Laboratories Limited entered a strategic advisory collaboration with Niraga Capitals Private Limited to support its growth, corporate development, and strategic initiatives.

Quest Laboratories Business Update

Quest Laboratories updated its third-quarter business position, reporting export orders of ₹10.71 Crore and domestic sales of ₹16.90 Crore, with a total order book of ₹39.73 Crore.

Order book

₹39.73 Cr

Quest Laboratories Capacity Expansion

Quest Laboratories Limited completed its Phase-I manufacturing expansion, with a new 12,000 sq. ft. facility becoming operational in September 2026.

building expansion area

12000.0 sq. ft.

Quest Laboratories Annual General Meeting

Quest Laboratories Limited has scheduled its 28th Annual General Meeting for September 30, 2026, to transact agenda items including financial statements and director appointments.

Quest Laboratories Business Update

Quest Laboratories entered a strategic growth and investment facilitation agreement with Niraga Capitals and a consortium. The partnership aims to scale operations and prepare for Mainboard listing.

Execution

5 years

Quest Laboratories Business Update

Quest Laboratories will change its financial result disclosure frequency from quarterly to half-yearly. This change is effective from the 2026-27 financial year.

Quest Laboratories Other Announcement

Quest Laboratories Limited filed its SDD Compliance Certificate for FY2026. The certificate confirms adherence to SEBI Insider Trading regulations regarding Structured Digital Database maintenance.

Quest Laboratories Q4 FY26 Results: Net Profit ₹2.9 Cr, Up 52.6% YoY

Quest Laboratories Ltd reported revenue from operations of ₹32.4 Cr (-30.3% YoY) and net profit of ₹2.9 Cr (+52.6% YoY) for Q4 FY26.

Key figure

Net profit ₹2.9 Cr · +52.6% YoY

Quest Laboratories Financial Results

Quest Laboratories Limited reported audited standalone net profit of ₹15.02 Crore for FY2026. The board also approved internal, secretarial, and cost auditor appointments.

Quest Laboratories Board Meeting Date

Quest Laboratories Limited scheduled a May 29 board meeting to consider audited annual results. The trading window remains closed until June 1, 2026.

Quest Laboratories Q3 FY26 Results: Net Profit ₹4 Cr, Up 400.0% YoY

Quest Laboratories Ltd reported net profit of ₹4 Cr (+400.0% YoY) for Q3 FY26.

Key figure

Net profit ₹4 Cr · +400.0% YoY